Lv2
130 积分 2026-02-12 加入
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone
1个月前
已完结
The analysis of multiple omics and examination of pathological images revealed the prognostic and therapeutic significances of CD93 in lung squamous cell carcinoma
1个月前
已完结
Integrative multi‐omic and machine learning approach for prognostic stratification and therapeutic targeting in lung squamous cell carcinoma
1个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
Bioinformatics Analysis Reveals Candidate Biomarkers Served As Dendritic Cell-based Lung Squamous CellCarcinoma (LUSC) Treatment
2个月前
已完结
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
2个月前
已完结
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
2个月前
已完结
Ivonescimab: First Approval
2个月前
已完结
Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer
3个月前
已完结
Anlotinib-Induced Hypertension: Current Concepts and Future Prospects
3个月前
已完结
皖公网安备34019202002308
